发明名称 Combination of calcium (3S) tetrahydro-3-furanyl(1S,2R)-3- [[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate with ritonavir
摘要 The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses. <CHEM>
申请公布号 EP1240903(A3) 申请公布日期 2003.02.12
申请号 EP20020013136 申请日期 1999.07.15
申请人 GLAXO GROUP LIMITED 发明人 ARMITAGE, IAN GORDON;SEARLE, ANDREW DAVID;SINGH, HARDEV
分类号 A61K31/665;A61K38/55;A61P31/12;A61P31/14;A61P31/18;A61P37/04;C07F9/655;(IPC1-7):A61K38/55 主分类号 A61K31/665
代理机构 代理人
主权项
地址